Nevertheless, we observed that high expression of FGF2 and the co-expressions of FGF2 & PDGF-B and FGF2 & VEGFR-3 are significant independent negative prognostic factors in widely resected non-GIST STS patients. This evidence concerns the gene PDGFB and gastrointestinal stromal tumor.